Interpreting neurologic outcomes in a changing trial design landscape

An analysis of heartware left ventricular assist device using a hybrid intention to treat population

Claudius Mahr*, Duc Thinh Pham, Nahush A. Mokadam, Scott C. Silvestry, Jennifer Cowger, Michael S. Kiernan, David A. D'Alessandro, Erin E. Coglianese, Muhammad Faraz Masood, Robert L. Kormos, Mary V. Jacoski, Jeffrey J. Teuteberg

*Corresponding author for this work

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Randomized controlled trials can provide optimal clinical evidence to assess the benefits of new devices, and it is these data that often shape device usage in real-world practice. However, individual clinical trial results sometimes appear discordant for the same device, and alternative devices are sometimes not employed in similar patient populations. To make sound evidence-based decisions, clinicians routinely rely on cross-trial comparisons from different trials of similar but not identical patient populations to assess competing technology when head-to-head randomized comparisons are unavailable.

Original languageEnglish (US)
Pages (from-to)293-296
Number of pages4
JournalASAIO Journal
Volume65
Issue number3
DOIs
StatePublished - Mar 1 2019

Fingerprint

Left ventricular assist devices
Heart-Assist Devices
Nervous System
Acoustic waves
Equipment and Supplies
Population
Randomized Controlled Trials
Clinical Trials
Technology

Keywords

  • advanced heart failure
  • left ventricular assist device
  • stroke

ASJC Scopus subject areas

  • Biophysics
  • Bioengineering
  • Biomaterials
  • Biomedical Engineering

Cite this

Mahr, Claudius ; Pham, Duc Thinh ; Mokadam, Nahush A. ; Silvestry, Scott C. ; Cowger, Jennifer ; Kiernan, Michael S. ; D'Alessandro, David A. ; Coglianese, Erin E. ; Faraz Masood, Muhammad ; Kormos, Robert L. ; Jacoski, Mary V. ; Teuteberg, Jeffrey J. / Interpreting neurologic outcomes in a changing trial design landscape : An analysis of heartware left ventricular assist device using a hybrid intention to treat population. In: ASAIO Journal. 2019 ; Vol. 65, No. 3. pp. 293-296.
@article{33f7d8dcfcd241578007cae924fa9f67,
title = "Interpreting neurologic outcomes in a changing trial design landscape: An analysis of heartware left ventricular assist device using a hybrid intention to treat population",
abstract = "Randomized controlled trials can provide optimal clinical evidence to assess the benefits of new devices, and it is these data that often shape device usage in real-world practice. However, individual clinical trial results sometimes appear discordant for the same device, and alternative devices are sometimes not employed in similar patient populations. To make sound evidence-based decisions, clinicians routinely rely on cross-trial comparisons from different trials of similar but not identical patient populations to assess competing technology when head-to-head randomized comparisons are unavailable.",
keywords = "advanced heart failure, left ventricular assist device, stroke",
author = "Claudius Mahr and Pham, {Duc Thinh} and Mokadam, {Nahush A.} and Silvestry, {Scott C.} and Jennifer Cowger and Kiernan, {Michael S.} and D'Alessandro, {David A.} and Coglianese, {Erin E.} and {Faraz Masood}, Muhammad and Kormos, {Robert L.} and Jacoski, {Mary V.} and Teuteberg, {Jeffrey J.}",
year = "2019",
month = "3",
day = "1",
doi = "10.1097/MAT.0000000000000931",
language = "English (US)",
volume = "65",
pages = "293--296",
journal = "ASAIO Journal",
issn = "1058-2916",
publisher = "Lippincott Williams and Wilkins",
number = "3",

}

Mahr, C, Pham, DT, Mokadam, NA, Silvestry, SC, Cowger, J, Kiernan, MS, D'Alessandro, DA, Coglianese, EE, Faraz Masood, M, Kormos, RL, Jacoski, MV & Teuteberg, JJ 2019, 'Interpreting neurologic outcomes in a changing trial design landscape: An analysis of heartware left ventricular assist device using a hybrid intention to treat population', ASAIO Journal, vol. 65, no. 3, pp. 293-296. https://doi.org/10.1097/MAT.0000000000000931

Interpreting neurologic outcomes in a changing trial design landscape : An analysis of heartware left ventricular assist device using a hybrid intention to treat population. / Mahr, Claudius; Pham, Duc Thinh; Mokadam, Nahush A.; Silvestry, Scott C.; Cowger, Jennifer; Kiernan, Michael S.; D'Alessandro, David A.; Coglianese, Erin E.; Faraz Masood, Muhammad; Kormos, Robert L.; Jacoski, Mary V.; Teuteberg, Jeffrey J.

In: ASAIO Journal, Vol. 65, No. 3, 01.03.2019, p. 293-296.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Interpreting neurologic outcomes in a changing trial design landscape

T2 - An analysis of heartware left ventricular assist device using a hybrid intention to treat population

AU - Mahr, Claudius

AU - Pham, Duc Thinh

AU - Mokadam, Nahush A.

AU - Silvestry, Scott C.

AU - Cowger, Jennifer

AU - Kiernan, Michael S.

AU - D'Alessandro, David A.

AU - Coglianese, Erin E.

AU - Faraz Masood, Muhammad

AU - Kormos, Robert L.

AU - Jacoski, Mary V.

AU - Teuteberg, Jeffrey J.

PY - 2019/3/1

Y1 - 2019/3/1

N2 - Randomized controlled trials can provide optimal clinical evidence to assess the benefits of new devices, and it is these data that often shape device usage in real-world practice. However, individual clinical trial results sometimes appear discordant for the same device, and alternative devices are sometimes not employed in similar patient populations. To make sound evidence-based decisions, clinicians routinely rely on cross-trial comparisons from different trials of similar but not identical patient populations to assess competing technology when head-to-head randomized comparisons are unavailable.

AB - Randomized controlled trials can provide optimal clinical evidence to assess the benefits of new devices, and it is these data that often shape device usage in real-world practice. However, individual clinical trial results sometimes appear discordant for the same device, and alternative devices are sometimes not employed in similar patient populations. To make sound evidence-based decisions, clinicians routinely rely on cross-trial comparisons from different trials of similar but not identical patient populations to assess competing technology when head-to-head randomized comparisons are unavailable.

KW - advanced heart failure

KW - left ventricular assist device

KW - stroke

UR - http://www.scopus.com/inward/record.url?scp=85064884418&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85064884418&partnerID=8YFLogxK

U2 - 10.1097/MAT.0000000000000931

DO - 10.1097/MAT.0000000000000931

M3 - Article

VL - 65

SP - 293

EP - 296

JO - ASAIO Journal

JF - ASAIO Journal

SN - 1058-2916

IS - 3

ER -